[Treatment of male osteoporosis].
Iba
Kazuko
K
Division of Internal Medicine, Osaka Municipal Kohsaiin Hospital.
D019386:Alendronate / Q000627:therapeutic use; D000469:Alkaline Phosphatase / Q000097:blood; D000596:Amino Acids / Q000652:urine; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D002118:Calcium / Q000627:therapeutic use; D015775:Fractures, Stress / Q000209:etiology; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000175:diagnosis / Q000209:etiology; D010446:Peptide Fragments / Q000652:urine; D011347:Procollagen / Q000652:urine; D012015:Reference Standards; D013739:Testosterone / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D000596:Amino Acids; D015415:Biomarkers; D010446:Peptide Fragments; D011347:Procollagen; C047202:procollagen Type I N-terminal peptide; D014807:Vitamin D; D013739:Testosterone; C036020:deoxypyridinoline; D000469:Alkaline Phosphatase; D002118:Calcium; D019386:Alendronate